The mutations impair acetylation of histones and transcriptional activation of CREBBP targets, including genes that are important for conferring glucocorticoid sensitivity on BCP-ALL cells, like RGS16 or DUSP10 [113,114]. The gene discussed is CREBBP; the disease is acute lymphoblastic leukemia.